SCHEME OVERVIEW

UTI Healthcare Fund - Regular Plan - IDCW

(Erstwhile UTI Pharma & Healthcare Fund-Income Option)

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 28-06-1999
Asset Class: Equity
Benchmark: BSE Healthcare TRI
Expense Ratio: 2.25% As on (30-04-2025)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 1,062.25 Cr As on (30-05-2025)
Turn over: 27
NAV as on 13-06-2025

219.8295

-0.28 (-0.1274%)

CAGR Since Inception

14.07%

BSE Healthcare TRI 15.03%

PERFORMANCE of UTI Healthcare Fund - Regular Plan - IDCW

Scheme Performance (%) Data as on - 13-06-2025

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
UTI Healthcare Fund - Regular Plan - IDCW 20.88 26.75 22.01 12.37 14.07
Benchmark - - - - -
Equity: Sectoral-Pharma and Healthcare 16.88 25.4 21.83 13.28 17.65

Yearly Performance (%)

Nav Movement

Fund Managers

Mr. Kamal Gada FM 1,Not Applicable FM 2,Not Applicable FM 3

Investment Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

RETURNS CALCULATOR for UTI Healthcare Fund - Regular Plan - IDCW

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Key Performance and Risk Statistics of UTI Healthcare Fund - Regular Plan - IDCW

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
UTI Healthcare Fund - Regular Plan - IDCW 14.3 0.49 -0.58 0.92 - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION

Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
UTI Healthcare Fund - Regular Plan - IDCW 28-06-1999 20.88 35.02 26.75 22.01 12.37
HDFC Pharma and Healthcare Fund - Growth Option 04-10-2023 26.66 0.0 0.0 0.0 0.0
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth 06-02-2024 26.51 0.0 0.0 0.0 0.0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 25-07-2018 21.93 38.35 29.75 25.03 0.0
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 20.88 35.02 26.75 22.01 12.37
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 19.31 32.33 29.09 24.17 12.53
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 08-11-2021 16.47 28.82 23.74 0.0 0.0
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 16.42 29.87 26.26 23.34 0.0
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 15.77 31.5 23.56 22.02 0.0
LIC MF Healthcare Fund-Regular Plan-Growth 22-02-2019 15.15 29.98 21.41 17.24 0.0

Asset Allocation (%)

PORTFOLIO ANALYSIS of UTI Healthcare Fund - Regular Plan - IDCW

Portfolio as on

Top 10 Sectors in portfolio (%)

Top 10 Stocks in portfolio (%)